ENTITY

Oncimmune Holdings (ONC LN)

Health CareUnited Kingdom
Oncimmune Limited develops and commercializes products for the detection of cancerous. It develops autoantibody assay technologies that have the potential to early detection a range of solid cancer tumor types. It offers EarlyCDT-Lung, a blood test that is ordered by a doctor to aid in the risk assessment and early detection of lung cancer in high-risk patients and to stratify indeterminate pulmonary nodules for the risk of malignancy. The company is based in Nottingham, the United Kingdom.
more
Exchange Announcement10 Dec 2024 23:36
Exchange Announcement04 Dec 2024 21:38
Exchange Announcement14 Nov 2024 01:06
Exchange Announcement13 Nov 2024 19:41
Exchange Announcement13 Nov 2024 01:17
x